Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression

Cancer Research

Volumn 61, Issue 5, 2001, Pages 2212-2219

  Pihan, German A ^a   Purohit, Aruna ^a   Wallace, Janice ^a   Malhotra, Raji ^a   Liotta, Lance ^b   Doxsey, Stephen J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER GROWTH; CELL ORGANELLE; CENTROSOME; GENOME; HUMAN; HUMAN CELL; METASTASIS; MITOSIS SPINDLE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER;

ANTIGENS; CENTROSOME; DISEASE PROGRESSION; HUMANS; MALE; PHENOTYPE; PROSTATIC NEOPLASMS;

EID: 0035266301     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Cancer statistics, 2000
2. The lifetime risk of developing prostate cancer in white and black men
3. Probabilities of eventually developing or dying of cancer-United States, 1985
4. Statistical and epidemiologic data on urologic cancer
5. The association of benign prostatic hyperplasia and cancer of the prostate
6. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer
7. Uncertainty in prostate cancer care: The physician's role in clearing the confusion
8. The challenge of prostate cancer
9. Classification of prostatic carcinomas
10. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging
11. Biological determinants of cancer progression in men with prostate cancer
12. Prognostic significance of DNA ploidy in carcinoma of prostate
13. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer
14. DNA ploidy by image analysis of individual foci of prostate cancer: A preliminary report
15. Flow cytometric DNA analysis of fresh prostatic resections
16. Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies
17. Centrosome defects and genetic instability in malignant tumors
18. The centrosome and cellular organization
19. Amorphous no longer: The centrosome comes into focus
20. Cell polarity: Intrinsic or externally imposed?
21. Polarity and nucleation of microtubules in polarized epithelial cells
22. Apical orientation of the microtubule organizing center and associated γ-tubulin during the polarization of the retinal pigment epithelium in vivo
23. Regulation and regulatory activities of centrosomes
24. Molecular chaperones and the centrosome
25. Four-dimensional control of the cell cycle
26. Cell cycle independent interaction of CDC2 with the centrosome, which is associated with the nuclear matrix-intermediate filament scaffold
27. The missing (L) UNC?
28. Control of centrosome reproduction: The right number at the right time
29. Pericentrin, a highly conserved centrosome protein involved in microtubule organization
30. Pericentrin and γ-tubulin form a protein complex and are organized into a novel lattice at the centrosome
31. Direct interaction of pericentrin with cytoplasmic dynein light intermediate chain contributes to mitotic spindle organization
32. Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software photoshop and matlab
33. Genetic instability in colorectal cancers
34. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens
35. Transformation of NIH 3T3 fibroblasts by an activated form of p59hck
36. Zonal origin of prostatic adenocarcinoma: Are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland?
37. Three-dimensional, DNA image cytometry by confocal scanning laser microscopy in thick tissue blocks of prostatic lesions
38. Application of confocal scanning laser microscopy to 3-D DNA image cytometry of prostatic lesions
39. Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis
40. DNA heterogeneity determined by flow cytometry in prostatic adenocarcinoma-necessitating multiple site analysis
41. γ-Tubulin complexes: Binding to the centrosome, regulation, and microtubule nucleation
42. Cytoplasmic dynein-mediated assembly of pericentrin and γ-tubulin onto centrosomes
43. Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: Pathogenetic and clinical implications
44. Prostatic microcarcinomas in relation to cancer origin and the evolution to clinical cancer
45. The mitotic machinery as a source of genetic instability in cancer
46. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations